title: Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification.
abstract: We report karyotypic analysis of 24 male germ cell tumors (GCTs) with clonally abnormal karyotypes biopsied from testicular and extragonadal lesions from 20 patients belonging to the histologic categories seminoma, teratoma, embryonal carcinoma, choriocarcinoma, and endodermal sinus tumor. Chromosomes 1, 7, 9, 12, 17, 21, 22, and the X chromosome were nonrandomly gained in these tumors. Nonrandom structural changes affected most frequently chromosomes 1 and 12, the latter as i(12p) and/or del(12)(q13----q22). The i(12p) was seen in 90% of tumors which included all histologic subtypes and gonadal as well as extragonadal presentation. Our present results, along with those from published data on fresh GCT biopsies, establish that i(12p) is a highly nonrandom chromosome marker of all histologic as well as anatomic presentations of GCTs. in contrast, we found del(12)(q13----q22) exclusively in nonseminomatous GCTs (NSGCTs) and mixed GCTs (MGCTs) occurring in 44% of such lesions. Because successful cytogenetic analysis of fresh tumor specimens is not always possible, we developed a method based on DNA analysis to detect i(12p) as increased copy number of 12p. In addition to the changes affecting chromosome 12 identified above, we have detected, for the first time, cytological evidence of gene amplification in the form of homogeneously staining regions (HSRs) and double minute chromosomes (dmins) in treated as well as untreated primary extragonadal and metastatic GCTs and confirmed the presence of amplified DNA in one of these tumors at the molecular level by the in-gel renaturation method. Hybridization of DNA from cultured cells from an HSR-bearing tumor with a panel of probes for genes known to be amplified or otherwise perturbed in diverse tumor systems did not identify the amplified gene, suggesting amplification of a novel gene or genes. This study comprises the largest series of GCT cytogenetics attempted so far. Notably, it includes data on a series of primary mediastinal tumors, a group which previously has not been studied in any detail.
authors.affiliation: Laboratory of Cancer Genetics, Sloan-Kettering Institute, New York, New York.
authors.forename: F
authors.initials: F
authors.lastname: Samaniego
authors.forename: E
authors.initials: E
authors.lastname: Rodriguez
authors.forename: J
authors.initials: J
authors.lastname: Houldsworth
authors.forename: V V
authors.initials: VV
authors.lastname: Murty
authors.forename: M
authors.initials: M
authors.lastname: Ladanyi
authors.forename: K P
authors.initials: KP
authors.lastname: Lele
authors.forename: Q G
authors.initials: QG
authors.lastname: Chen
authors.forename: E
authors.initials: E
authors.lastname: Dmitrovsky
authors.forename: N L
authors.initials: NL
authors.lastname: Geller
authors.forename: V
authors.initials: V
authors.lastname: Reuter
mesh_terms: D015139:Blotting, Southern; D002869:Chromosome Aberrations / Q000235:genetics*; D025063:Chromosome Disorders; D002881:Chromosomes, Human, Pair 12; D003001:Cloning, Molecular; D004273:DNA, Neoplasm / Q000235:genetics; D005784:Gene Amplification / Q000235:genetics*; D006801:Humans; D007621:Karyotyping; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D009695:Nucleic Acid Renaturation
chemical_list: D004273:DNA, Neoplasm